Your browser doesn't support javascript.
loading
Endocrine Disorders and COVID-19.
Oguz, Seda Hanife; Yildiz, Bulent Okan.
Afiliação
  • Oguz SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey; email: yildizbo@yahoo.com.
  • Yildiz BO; Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey; email: yildizbo@yahoo.com.
Annu Rev Med ; 74: 75-88, 2023 01 27.
Article em En | MEDLINE | ID: mdl-36151047
The multifaceted interaction between coronavirus disease 2019 (COVID-19) and the endocrine system has been a major area of scientific research over the past two years. While common endocrine/metabolic disorders such as obesity and diabetes have been recognized among significant risk factors for COVID-19 severity, several endocrine organs were identified to be targeted by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). New-onset endocrine disorders related to COVID-19 were reported while long-term effects, if any, are yet to be determined. Meanwhile, the "stay home" measures during the pandemic caused interruption in the care of patients with pre-existing endocrine disorders and may have impeded the diagnosis and treatment of new ones. This review aims to outline this complex interaction between COVID-19 and endocrine disorders by synthesizing the current scientific knowledge obtained from clinical and pathophysiological studies, and to emphasize considerations for future research.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / COVID-19 Limite: Humans Idioma: En Revista: Annu Rev Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / COVID-19 Limite: Humans Idioma: En Revista: Annu Rev Med Ano de publicação: 2023 Tipo de documento: Article